GAGNO, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.071
AS - Asia 1.810
EU - Europa 688
AF - Africa 254
SA - Sud America 251
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 26
Totale 5.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.910
SG - Singapore 540
VN - Vietnam 413
CN - Cina 290
IT - Italia 172
BR - Brasile 171
HK - Hong Kong 132
BD - Bangladesh 111
DE - Germania 90
FI - Finlandia 65
IN - India 49
FR - Francia 45
PL - Polonia 43
CA - Canada 40
RU - Federazione Russa 34
TR - Turchia 30
GB - Regno Unito 29
MX - Messico 24
NL - Olanda 22
ZA - Sudafrica 21
SA - Arabia Saudita 19
ID - Indonesia 18
IQ - Iraq 18
JP - Giappone 18
PK - Pakistan 17
AT - Austria 15
CO - Colombia 15
EG - Egitto 14
UA - Ucraina 14
AR - Argentina 13
KR - Corea 13
EC - Ecuador 12
HR - Croazia 12
MA - Marocco 12
PH - Filippine 12
PY - Paraguay 12
IE - Irlanda 11
KG - Kirghizistan 10
SE - Svezia 10
TH - Thailandia 10
AL - Albania 9
BJ - Benin 9
CL - Cile 9
DZ - Algeria 9
NZ - Nuova Zelanda 9
RO - Romania 9
UZ - Uzbekistan 9
YT - Mayotte 9
CW - ???statistics.table.value.countryCode.CW??? 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
ES - Italia 8
GN - Guinea 8
GT - Guatemala 8
HN - Honduras 8
NI - Nicaragua 8
TT - Trinidad e Tobago 8
UG - Uganda 8
AM - Armenia 7
AO - Angola 7
BE - Belgio 7
CG - Congo 7
CI - Costa d'Avorio 7
LT - Lituania 7
ML - Mali 7
NP - Nepal 7
RE - Reunion 7
SN - Senegal 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
AZ - Azerbaigian 6
BY - Bielorussia 6
CD - Congo 6
CR - Costa Rica 6
DJ - Gibuti 6
ET - Etiopia 6
GA - Gabon 6
GM - Gambi 6
JO - Giordania 6
KE - Kenya 6
LA - Repubblica Popolare Democratica del Laos 6
LY - Libia 6
ME - Montenegro 6
MG - Madagascar 6
MY - Malesia 6
NA - Namibia 6
PS - Palestinian Territory 6
PT - Portogallo 6
TN - Tunisia 6
AD - Andorra 5
BA - Bosnia-Erzegovina 5
BB - Barbados 5
BG - Bulgaria 5
BO - Bolivia 5
BS - Bahamas 5
CM - Camerun 5
CV - Capo Verde 5
CY - Cipro 5
CZ - Repubblica Ceca 5
GE - Georgia 5
Totale 4.909
Salva come PNG Salva come JPEG
Città #
Ashburn 388
Singapore 351
San Jose 300
Ho Chi Minh City 136
Hong Kong 117
Hanoi 115
Chandler 101
Fairfield 84
Beijing 82
Santa Clara 76
Los Angeles 57
Munich 47
Ann Arbor 42
New York 42
Cambridge 39
Houston 35
Seattle 35
Boardman 32
Bytom 31
Helsinki 31
Buffalo 30
Woodbridge 30
Wilmington 29
Council Bluffs 28
Lauterbourg 23
Milan 21
Chicago 20
San Diego 19
Turku 19
Dallas 18
São Paulo 18
Da Nang 17
Padova 16
Princeton 16
Des Moines 15
Johannesburg 14
Medford 14
Haiphong 13
Rome 13
Tokyo 13
Montreal 12
Orem 12
London 11
Naples 11
Bishkek 10
Bến Tre 10
Cairo 10
Guangzhou 10
Toronto 10
Biên Hòa 9
Jeddah 9
Vienna 9
Auckland 8
Charlotte 8
Conakry 8
Cotonou 8
Falkenstein 8
Hefei 8
Jakarta 8
Kampala 8
Managua 8
Tirana 8
Trieste 8
Abidjan 7
Frankfurt am Main 7
Hải Dương 7
Tashkent 7
Amman 6
Ankara 6
Baghdad 6
Baku 6
Cagliari 6
Chennai 6
Dakar 6
Dublin 6
Kinshasa 6
Lappeenranta 6
Luanda 6
Nairobi 6
New Delhi 6
Ninh Bình 6
Rio de Janeiro 6
Riyadh 6
Salt Lake City 6
Warsaw 6
Willemstad 6
Yerevan 6
Andorra la Vella 5
Bamako 5
Bogotá 5
Bridgetown 5
Brooklyn 5
Dushanbe 5
Guayaquil 5
Harare 5
Las Vegas 5
Libreville 5
Mamoudzou 5
Nassau 5
Noumea 5
Totale 2.951
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics biomarkers and their specific role in neoadjuvant chemoradiotherapy treatments: An exploratory study on rectal cancer patients 273
Innovative strategies for tailoring therapy in cancer patient: pharmacogenetics and hormone therapy personalization in metastatic or locally advanced breast cancer patients treated with Exemestane 246
Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy 240
A new high-performance liquid chromatography–tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine 231
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer 223
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions 213
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis 208
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer 204
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure 202
A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma 197
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 196
Il15ra and smad3 genetic variants predict overall survival in metastatic colorectal cancer patients treated with folfiri therapy: A new paradigm 192
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 189
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients 185
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method 179
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 177
Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations 176
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer 173
Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring 172
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure 166
A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring 164
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring 164
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 162
Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series 159
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring 158
Therapeutic drug monitoring of palbociclib, ribociclib and letrozole in women with breast cancer by LC-MS 156
A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot 135
Totale 5.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.552
article - articoli 13.866
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.418
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022191 0 32 11 13 4 20 12 18 8 19 14 40
2022/2023190 25 32 4 25 27 25 2 10 18 4 13 5
2023/2024115 4 11 8 11 7 27 11 13 3 5 6 9
2024/2025839 7 78 31 42 68 46 30 80 45 44 134 234
2025/20263.370 195 205 390 386 332 143 593 273 332 188 222 111
2026/2027145 117 28 0 0 0 0 0 0 0 0 0 0
Totale 5.140